CSafe Global is launching its new AcuTemp Plus Series to address the cold chain needs of commercial pharma, clinical trials, and cell and gene therapies. The passive packaging features high-performing Vacuum Insulated Panels (VIP) and single temperature phase change material (PCM), with CSafe saying this enhanced series is optimally designed for performance, simplicity and efficiency.
“The AcuTemp Plus Series has been developed with our customers in mind, offering them the level of performance and quality they expect, while delivering the peace of mind they deserve,” says Patrick Schafer, CEO of CSafe Global. “The new AcuTemp Plus Series represents a new era in reusable VIP passive packaging, providing an end-to-end cold chain solution with an industry-leading level of temperature performance.”
With years of experience in the cold chain packaging industry, CSafe highlights that not all thermal solutions are created equal. “CSafe developed this next-generation, high-performance packaging solution from the ultimate combination of proprietary VIP and enhanced PCM technology,” the company says. “Test results of the new product range have been impressive with temperature performances outlasting other market available solutions by a large margin.”
CSafe says it invests in R&D efforts to more optimally meet customer needs and provide the best user experience possible. “Additionally, the AcuTemp Plus Series has been designed for efficiency, leveraging a fully managed end-to-end retest and reuse programme – REPAQ. With this industry-first reuse program, CSafe is uniquely dedicated to thermally re-qualifying VIP panels on every parcel shipper returned, to guarantee ‘like new’ performance of the reusable packaging solution.”
As an indispensable cold chain partner, CSafe says it is committed to innovation, continuous improvement, and unparalleled customer service. “With its industry-leading portfolio of temperature-management solutions, it is CSafe’s mission to bring peace of mind to the cold chain of every life-science customer, protecting their vital shipments, so that patients can receive what matters most to them.”